Objective We aimed to evaluate the association of height of fever with invasive bacterial infection (IBI) among febrile infants <=60 days of age.
Methods In a secondary analysis of a multicentre case–control study of non-ill-appearing febrile infants <=60 days of age, we compared the maximum temperature (at home or in the emergency department) for infants with and without IBI. We then computed interval likelihood ratios (iLRs) for the diagnosis of IBI at each half-degree Celsius interval.
Results The median temperature was higher for infants with IBI (38.8°C; IQR 38.4–39.2) compared with those without IBI (38.4°C; IQR 38.2–38.9) (p<0.001). Temperatures 39°C–39.4°C and 39.5°C–39.9°C were associated with a higher likelihood of IBI (iLR 2.49 and 3.40, respectively), although 30.4% of febrile infants with IBI had maximum temperatures <38.5°C.
Conclusions Although IBI is more likely with higher temperatures, height of fever alone should not be used for risk stratification of febrile infants.
- accident & emergency
- infectious diseases
Data availability statement
De-identified data are available upon reasonable request if a data use agreement is executed between the requesting institution and Yale.
Statistics from Altmetric.com
Correction notice This paper has been corrected since it was published online. A degree symbol has been added before the ‘C’.
Collaborators The following collaborators in the Febrile Young Infant Research Collaborative acquired data for this study and/or contributed to the parent study: Elizabeth R Alpern, MD, MSCE (Ann and Robert H Lurie Children’s Hospital of Chicago, Chicago, Illinois), Whitney L Browning, MD (Vanderbilt University School of Medicine, Nashville, Tennessee), Elana A Feldman, MD (Lucile Packard Children’s Hospital Stanford, Palo Alto, California), Catherine E Lumb, MD (University of Alabama at Birmingham, Birmingham, Alabama), Russell J McCulloh, MD (Children’s Mercy Hospital, Kansas City, Missouri), Christine E Mitchell, BSN (Children's Hospital of Philadelphia, Philadelphia, Pennsylvania), Lise E Nigrovic, MD, MPH (Boston Children’s Hospital, Boston, Massachusetts), Nipam Shah, MBBS, MPH (University of Alabama at Birmingham, Birmingham, Alabama), Samir S Shah, MD, MSCE (University of Cincinnati College of Medicine, Cincinnati, Ohio), Sarah J Shin, BSN (Children's Hospital of Philadelphia, Philadelphia, Pennsylvania), and Derek J Williams, MD, MPH (Vanderbilt University School of Medicine, Nashville, Tennessee).
Contributors Study concept and design: KAM, MIN, PLA. Data acquisition: MIN, CMP, SD, MEW, AGD, RCL, LFS, RDM, SNR, CW, FB, PLA. Data analysis: KAM, PLA. Interpretation of data: all authors. Drafting of the initial manuscript: KAM, PLA. Critical revision of the manuscript for important intellectual content: all authors. Statistical analysis: KAM. Study supervision: PLA. Approval of the final manuscript for submission and agreement to be accountable for all aspects of the work: all authors.
Funding This project was supported by grant numbers K08HS026503 (KM) and K08HS026006 (PA) from the Agency for Healthcare Research and Quality (AHRQ) and by CTSA grant number KL2 TR001862 (PA) from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not represent the official views of AHRQ or NIH.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.